Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results, Exceeding or Meeting Full Year 2020 Financial Guidance; Provides Full Year 2021 Financial Guidance

Go back to Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results, Exceeding or Meeting Full Year 2020 Financial Guidance; Provides Full Year 2021 Financial Guidance
IRONWOOD PHARMA-A (NASDAQ: IRWD) Delayed: 3.54 +0.02 (0.57%)
Previous Close $3.52    52 Week High $16.89 
Open $3.59    52 Week Low $7.35 
Day High $3.65    P/E N/A 
Day Low $3.49    EPS $-2.35 
Volume 4,942,496